Capvizr
THE DEAL, AT A GLANCE

Clinical ink

From the announcement
01What it does<strongClinical ink provides electronic clinical outcome assessments (eCOA), connected devices and other eClinical technologies</strong.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by Ardan EquityFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedClinical ink raised Pre-Seed, announced 2026-10-20From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Clinical ink · Financing Record

Explore source-linked visual explanations for Clinical ink. Unsupported claims are withheld while source review continues.

Record 14486 · Recorded date: 2026-10-20

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 14486 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime